Your session is about to expire
← Back to Search
LY3857210 for Chronic Lower Back Pain
Study Summary
This trial tests a new drug to ease chronic back pain. It's part of a protocol to develop better pain treatments.
- Chronic Lower Back Pain
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you provide insight into the potential risks of LY3857210 for individuals?
"The safety of this drug is assumed to be a 2, as no clinical data has been procured to verify efficacy yet; however, there are some studies that point towards its relative safety."
How many medical centers are offering this clinical investigation?
"Multiple clinical centres across the US are recruiting for this trial, such as Arizona Research Center in Phoenix, Artemis Institute for Clinical Research in Riverside and CMR of Greater New Haven, LLC in San Diego. In total there are 28 different sites looking to enrol patients."
Are there any vacancies available within this clinical trial?
"According to clinicaltrials.gov, recruitment for this medical trial is still ongoing since it was first announced on December 8th 2022 and last modified on January 3rd 2023."
To what capacity has this research trial been populated?
"Affirmative. According to the clinicaltrials.gov database, this study began accepting patients on December 8th 2022 and was last updated January 3rd 2023. It is currently recruiting 125 participants from 28 different sites across the US."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger